1-3 of 3
Benjamin H. Durham
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Mutant PIK3CA is a targetable driver alteration in histiocytic neoplasms

Clinical Trials & Observations
Benjamin H. Durham, Oshrat Hershkovitz-Rokah, Omar Abdel-Wahab, Mariko Yabe, Young Rock Chung, Gilad Itchaki, Maayan Ben-Sasson, Vered A. Asher-Guz, David Groshar, Seyram A. Doe-Tetteh, Tina Alano, David B. Solit, Ofer Shpilberg, Eli L. Diamond, Roei D. Mazor
Journal: Blood Advances
Blood Adv (2023) 7 (23): 7319–7328.
https://doi.org/10.1182/bloodadvances.2022009349
Published: 2023
Includes: Supplemental data
Journal Articles

Histiocytic neoplasm subtypes differ in their MAP2K1 mutational type

Jean-François Emile, Zofia Hélias-Rodzewicz, Benjamin H. Durham, Sébastien Héritier, Malik da Silva, Komel Younas, Fleur Cohen-Aubart, Omar Abdel-Wahab, Eli L. Diamond, Jean Donadieu, Julien Haroche
Journal: Blood Advances
Blood Adv (2023) 7 (23): 7254–7257.
https://doi.org/10.1182/bloodadvances.2023011414
Published: 2023
Includes: Supplemental data
Journal Articles

The clinical spectrum of Erdheim-Chester disease: an observational cohort study

Clinical Trials & Observations
Juvianee I. Estrada-Veras, Kevin J. O’Brien, Louisa C. Boyd, Rahul H. Dave, Benjamin H. Durham, Liqiang Xi, Ashkan A. Malayeri, Marcus Y. Chen, Pamela J. Gardner, Jhonell R. Alvarado Enriquez, Nikeith Shah, Omar Abdel-Wahab, Bernadette R. Gochuico, Mark Raffeld, Elaine S. Jaffe, William A. Gahl
Journal: Blood Advances
Blood Adv (2017) 1 (6): 357–366.
https://doi.org/10.1182/bloodadvances.2016001784
Published: 2017
Includes: Supplemental data